Recent Security Class Actions

Fulgent Genetics Inc. Common Stock (NASDAQ: FLGT)

53 Days left to seek lead plaintiff status.

Company Name:Fulgent Genetics Inc. Common Stock
Stock Symbol:NASDAQ: FLGT
Class Period Start:03/22/2019
Class Period End (inclusive):08/04/2022
Filing Deadline:11/21/2022

The Complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements regarding the Company’s business, operations, and compliance policies. Specifically, the Complaint alleges Defendants made false and/or misleading statements and/or failed to disclose that: (i) Fulgent had been conducting medically unnecessary laboratory testing, engaging in improper billing practices in relation to laboratory testing, and providing or receiving remuneration in violation of the Anti-Kickback Statute and Stark Law; (ii) accordingly, Fulgent was likely to become subject to enhanced legal and regulatory scrutiny; (iii) Fulgent’s revenues, to the extent they were derived from the foregoing unlawful conduct, were unsustainable; (iv) the foregoing, once revealed, was likely to subject the Company to significant financial and/or reputational harm; and (v) as a result, the Company’s public statements were materially false and misleading at all relevant times.

Fulgent Genetics Inc. Common Stock (NASDAQ: FLGT) Claim Form

Name(Required)
Address
Consent(Required)
This field is for validation purposes and should be left unchanged.